Arab cancer conference stresses co-operation:
This article was originally published in Clinica
Executive Summary
Last week's Pan Arab cancer congress hosted in Doha, Qatar, by the Qatar National Cancer Society (QNCS), concluded with a call for a more comprehensive approach to early detection, therapy and rehabilitation of patients. Delegates to the conference, which was attended by over 500 doctors from the Arab world, as well as experts from the US and Europe, heard that more interaction was needed between Arab states to control the disease. Proposals were also put forward to increase co-operation between Arab states and countries that were more advanced in cancer treatment.
You may also be interested in...
Beauty Firms Using AI-Based Tools Could Be Subject To Health Privacy Laws In US States
Using AI-based programs to collect and store consumer information risks running afoul of new health privacy laws cropping up in US states. Lack of federal regulation or guidance on the issue is one of the biggest challenges for beauty firms deploying AI, according to Stacy Marcus, partner at Reed Smith LLP.
Mustang Bio Enters Race For CAR-T In Autoimmune Disease
The biotech company’s CEO talked to Scrip about plans to bring the CD20-targeting CAR-T MB-106 into an investigator-sponsored Phase I trial later this year.
Aldeyra Hopes To Refile Dry Eye Drug Reproxalap Later In 2024
Following an FDA complete response letter last November, Aldeyra has agreed with the agency on a trial design to demonstrate efficacy in ocular discomfort, which the company can complete this year.